Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 1 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 12 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSH | $93.7B | 23.4× | 16.8× | 3.5× | 10.3% | — | 15.4% | 27.2% | 11.9% | 2.6× | 453 |
| AJG | $68.8B | 46.7× | — | 4.9× | 20.7% | — | 10.7% | 6.4% | 4.1% | — | 387 |
| AON | $68.3B | 18.9× | 18.2× | 4.0× | 9.4% | — | 21.5% | 39.5% | 15.0% | 3.1× | 324 |
| WTW | $29.8B | 19.7× | 13.4× | 3.1× | -2.2% | — | 16.5% | 20.1% | 11.2% | 1.3× | 172 |
| BRO | $22.5B | 21.5× | — | 3.8× | 22.8% | — | 17.9% | 8.4% | 5.2% | — | 216 |
| ACT | $6.6B | 10.6× | — | 5.3× | 2.8% | — | 54.6% | 12.6% | 11.1% | — | 56 |
| BWIN | $4.5B | — | 21.6× | 3.0× | 8.3% | — | -2.2% | -5.6% | -5.5% | -0.6× | 36 |
| CRVL | $4.2B | 38.4× | — | 4.3× | 7.0% | 24.3% | 11.5% | 28.0% | 28.0% | — | 61 |
| LIFE | $2.8B | 35.8× | 35.0× | 7.3× | 52.0% | 98.3% | 18.4% | -295% | -295% | -1.2× | 8 |
| TWFG | $1.5B | 51.2× | 23.8× | 5.9× | 22.0% | — | 16.6% | 49.4% | 47.1% | -2.8× | 5 |
| GSHD | $1.1B | 45.7× | 16.2× | 3.1× | 16.2% | — | 7.6% | -29.1% | 14.1% | 3.0× | 45 |
| WDH | $363M | 50.5× | 5.5× | 0.6× | 49.8% | — | 14.2% | 11.0% | 10.9% | -1.1× | 3 |
| HIT | $40M | 30.6× | 13.3× | 1.2× | 71.0% | 62.8% | 3.8% | 7.5% | 7.5% | -3.2× | 1 |
Peers = companies sharing HIT's sector (Insurance Agents, Brokers & Service) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
A reverse discounted cash flow is not shown for an insurer.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Classified from the filings: SIC code.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$56K FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Leverage ratios is not shown for an insurer.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2024 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $33.3M 100.0% | $19.5M 100.0% | $19.2M 100.0% |
| Cost of Revenue | $12.4M 37.2% | $4.1M 20.8% | $2.3M 12.0% |
| Gross Profit | $20.9M 62.8% | $15.4M 79.2% | $16.8M 88.0% |
| Research & Development | $1.6M 4.7% | $2.8M 14.4% | $2.0M 10.5% |
| Selling, General & Admin | $13.7M 41.0% | $8.5M 43.5% | $8.1M 42.2% |
| Total Operating Expenses | $19.4M 58.2% | $14.4M 74.1% | $13.5M 70.3% |
| Interest Expense | — | $495K 2.5% | $2K 0.0% |
| Interest & Investment Income | $410K 1.2% | $123K 0.6% | $41K 0.2% |
| Other Income (Expense), net | $146K 0.4% | -$101K -0.5% | $39K 0.2% |
| Pretax Income | $1.7M 5.0% | $889K 4.6% | $3.4M 17.9% |
| Income Tax Expense | $395K 1.2% | $219K 1.1% | $945K 4.9% |
| Net Income | $1.3M 3.8% | $670K 3.4% | $4.0M 20.7% |
| Per Share | |||
| EPS (Basic) | $0.02 | $0.01 | — |
| EPS (Diluted) | $0.02 | $0.01 | — |
| Weighted Avg Shares (Basic) | 55.8M | 51.8M | — |
| Weighted Avg Shares (Diluted) | 57.7M | 53.7M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 7% against ROIC 7% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cost of Revenue | 12.0 | 20.8 | 37.2 |
| Gross Profit | 88.0 | 79.2 | 62.8 |
| R&D | 10.5 | 14.4 | 4.7 |
| SG&A | 42.2 | 43.5 | 41.0 |
| Income Tax | 4.9 | 1.1 | 1.2 |
| Net Income | 20.7 | 3.4 | 3.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on HIT: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Cost of capital cannot be computed, so the spread is unknown.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2023 | 88.0% | 17.7% | 20.7% |
| FY2024 | 79.2% | 5.1% | 3.4% |
| FY2025 | 62.8% | 4.6% | 3.8% |
Return on equity (7%) and return on invested capital (7%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: wacc.
Cash conversion of 0.65x sits below the level that would make the earnings clearly cash-backed.
| Step | Amount | Running total |
|---|---|---|
| Net income | $1M | $1M |
| Share-based comp | $2M | $3M |
| Other non-cash & working capital | $284,552 | $3M |
| Operating cash flow | $3M | $3M |
| Capex | −$3M | −$56,108 |
| Free cash flow | −$56,108 | −$56,108 |
| FCF after SBC | −$2M | −$2M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2024 | 1.8% | -26.3% | -28.1 points |
| FY2025 | 71.0% | -54.1% | -125.1 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2023 | 42.6 days | not reported | 415.2 days | -372.6 days |
| FY2024 | 30.8 days | not reported | 167.5 days | -136.6 days |
| FY2025 | 8.3 days | not reported | 123.4 days | -115.1 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2023 | 21.1 percent |
| FY2024 | -9.6 percent |
| FY2025 | -8.0 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Reported free cash flow is -$56,108; after share-based compensation it is -$2M. The difference is a real cost that the cash flow statement adds back.
Leverage is not measurable this way for a insurer.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Funded by policyholder float, not debt. Reserve adequacy and RBC are the right questions and are not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $0.61, free cash flow must compound 16.82%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2024 | 231.7% | 16.8% |
| FY2025 | −104.4% | 16.8% |
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-20 | 4 co-filers Chief Executive Officer | Grant | 2,000,000 | $0.00 | $0 |
| 2026-10-20 | 4 co-filers Chief Executive Officer | Grant | 1,500,000 | $0.00 | $0 |
| 2026-10-20 | 4 co-filers Chief Executive Officer | Grant | 1,500,000 | $0.00 | $0 |
| 2026-10-20 | 4 co-filers Chief Executive Officer | Grant |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 500,000 |
| $0.00 |
| $0 |
| 2026-10-16 | 2 co-filers Chief Growth Officer | 10b5-1 plan sale | 3,333 | $0.62 | $2k |
| 2026-10-15 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 119,728 | $0.63 | $75k |
| 2026-10-15 | 2 co-filers Chief Growth Officer | Tax withholding | 6,756 | $0.63 | $4k |
| 2026-10-15 | Qian Linlin Chief Executive Officer | Tax withholding | 47,516 | $0.63 | $30k |
| 2026-10-07 | Howard William D. Director | Grant | 26,301 | $0.76 | $20k |
| 2026-10-07 | Hayes Timothy Director | Grant | 26,301 | $0.76 | $20k |
| 2026-09-15 | Hasan Zain Syed Chief Growth Officer | Tax withholding | 4,795 | $0.89 | $4k |
| 2026-09-15 | Qian Linlin Chief Executive Officer | Tax withholding | 33,725 | $0.89 | $30k |
| 2026-09-15 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 63,339 | $0.89 | $56k |
| 2026-09-14 | Hayes Timothy Director | Open-market sale | 12,000 | $0.89 | $11k |
| 2026-09-11 | Hasan Zain Syed Chief Growth Officer | 10b5-1 plan sale | 11,667 | $0.92 | $11k |
| 2026-09-11 | 2 co-filers Group filing | Open-market sale | 12,000 | $0.91 | $11k |
| 2026-09-09 | 2 co-filers Group filing | Open-market sale | 5,730 | $0.93 | $5k |
| 2026-08-13 | Qian Linlin Chief Financial Officer | Tax withholding | 28,183 | $1.06 | $30k |
| 2026-08-13 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 46,327 | $1.06 | $49k |
| 2026-08-13 | Hasan Zain Syed Chief Growth Officer | Tax withholding | 4,007 | $1.06 | $4k |
| 2026-07-15 | Hasan Zain Syed Chief Growth Officer | Tax withholding | 4,084 | $1.04 | $4k |
| 2026-07-15 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 47,217 | $1.04 | $49k |
| 2026-07-15 | Qian Linlin Chief Financial Officer | Tax withholding | 28,725 | $1.04 | $30k |
| 2026-07-08 | Shrestha Sanjay K Director | Grant | 18,867 | $1.06 | $20k |
| 2026-07-08 | Howard William D. Director | Grant | 18,867 | $1.06 | $20k |
| 2026-07-08 | Hayes Timothy Director | Grant | 18,867 | $1.06 | $20k |
| 2026-06-15 | Hasan Zain Syed Chief Growth Officer | Tax withholding | 4,045 | $1.05 | $4k |
| 2026-06-15 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 46,768 | $1.05 | $49k |
| 2026-06-15 | Qian Linlin Chief Financial Officer | Tax withholding | 28,451 | $1.05 | $30k |
| 2026-05-20 | Lockett Jonathan Del Chief Strategy Officer | Grant | 50,000 | $0.00 | $0 |
| 2026-05-14 | Qian Linlin Chief Financial Officer | Tax withholding | 23,324 | $1.23 | $29k |
| 2026-05-14 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 39,924 | $1.23 | $49k |
| 2026-05-14 | Hasan Zain Syed Chief Growth Officer | Tax withholding | 4,205 | $1.23 | $5k |
| 2026-04-15 | Johnson Tim Donald Chief Executive Officer | Tax withholding | 35,140 | $1.50 | $53k |
| 2026-04-15 | Hasan Zain Syed Chief Growth Officer | Tax withholding | 3,448 | $1.50 | $5k |
| 2026-04-15 | Qian Linlin Chief Financial Officer | Tax withholding | 21,480 | $1.50 | $32k |
| 2026-04-10 | Mcstravock John General Counsel | Grant | 5,000 | $0.00 | $0 |
| 2026-04-08 | Shrestha Sanjay K Director | Grant | 13,598 | $1.36 | $18k |
| 2026-04-08 | Howard William D. Director | Grant | 13,598 | $1.36 | $18k |
| 2026-04-08 | Hayes Timothy Director | Grant | 13,598 | $1.36 | $18k |